In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zymed Inc.

Division of Royal Philips NV

Latest From Zymed Inc.

Resuscitating a Culture One Beat at a Time

Its acquisition of privately held Zymed means more to the Healthcare Solutions Group (HSG) of Agilent Technologies than being able to fill a gap in its cardiology business. It is also a part of Agilent's drive to energize its corporate culture following its spin-out of Hewlett-Packard last year. Moreover, in the face of disappointing earnings from HSG and poor near-term growth prospects, Agilent's overall commitment to health care was questioned by Wall Street.
Medical Device Business Strategies

Agilent: Living Up to Its Name

Agilent was spun out of Hewlett-Packard in November 1999 to encourage some of its business units to shift toward higher-growth products that, as a part of a smaller company, could make a more significant contribution to earnings growth. The name evokes agility and efficiency, but over the past decade HP--in part a victim of its own success--had become somewhat complacent. To stimulate entrepreneurship, Agilent knows it has to change the culture it inherited. Moreover, its existing health-care businesses have not been performing well due to market conditions that are not expected to improve in the near term. The health care portion of the company now expects only minimal growth for the year, well below the double digit growth Agilent wants from its businesses. It therefore intends to step up development and introduction of new products, to decrease emphasis on the hospital-based market and grow its businesses in developing countries, and move into interactive health services and e-health. But that brings with it new challenges in marketing and partnering which were not its strong suit as part of HP.
Strategy Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Royal Philips NV
  • Senior Management
  • Gary Hutchinson, Pres. & CEO
    William Popok, CFO
    Hosmel Galan, EVP
  • Contact Info
  • Zymed Inc.
    Phone: (800) 235-5941
    1201 N. Rice Ave.
    Unit B
    Oxnard, CA 93030
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register